Mayo Clinic Platform and Techcyte announce a strategic collaboration

Jan. 22, 2024
Collaboration with a goal to transform the global practice of pathology.

Mayo Clinic Platform and Techcyte are working together with a hope to transform the global practice of pathology through the creation of a digital pathology platform.

The digital pathology platform will enable healthcare organizations worldwide to economically digitize their pathology practices and use innovative technical and AI workflow solutions. Through an open, end-to-end, AI driven solution, the digital pathology platform aims to advance treatments, enhance efficiency and accuracy, and allow for global access to pathology services.

The software as a service-based digital pathology platform is an extension of Techcyte’s clinical pathology platform and will create an open AI-enabled anatomic pathology ecosystem that is standards-driven and workflow-focused. The digital pathology platform will enable the integration of a diverse community of pathologists, LIS vendors, whole slide scanner manufacturers, storage, AI providers, biopharma, and labs.

This new effort builds upon a clinical pathology collaboration between Mayo Clinic and Techcyte to digitize diagnostic testing in lab medicine.

Techcyte release